Human IgM Antibody Conjugated to DyLight 488

Product Description

Anti Human IgM Antibody Conjugated to DyLight 488
Catalog number: B2010797
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: na
Supplied as: Lyophilized
Applications: multipurpose antibody for various assay formats, including ELISA
Storage: -20C
Keywords: IgM-Dylight 800 , IgM-Dylight 800
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Tanaka M, Nishizawa M, Inuzuka T, Baba H, Sato S, Miyatake T. Human natural killer cell activity is reduced by treatment of anti-myelin-associated glycoprotein (MAG) monoclonal mouse IgM antibody and complement J Neuroimmunol. 1985 Dec;10(2):115-27.
2: Arend P. Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM) Cancer Med. 2017 Jul;6(7):1601-1613.
3: Senda Y, Ohta K, Yokoyama T, Shimizu M, Furuichi K, Wada T, Yachie A. Microangiopathic antiphospholipid antibody syndrome due to anti-phosphatidylserine/prothrombin complex IgM antibody Pediatr Int. 2017 Mar;59(3):378-380.
4: Cavanna B, Jiang H, Allaria S, Carpo M, Scarlato G, Nobile-Orazio E. Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies J Neuroimmunol. 2001 Mar 1;114(1-2):226-31.
5: Orson FM, Rossen RD, Shen X, Lopez AY, Wu Y, Kosten TR. Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine Am J Addict. 2013 Mar-Apr;22(2):169-74.
6: Higashigawa M, Komada Y, Shimono Y, Nagata T, Inamochi H, Mao XY, M’soka T, Hori H, Kawasaki H, Sakurai M. FK506 inhibits anti-IgM antibody-induced apoptosis and 17 kD endonuclease activity in the human B-cell line, MBC-1, established from Burkitt’s lymphoma Br J Haematol. 1997 Dec;99(4):908-13.
7: Matsuura T, Imamura A, Ota T. [IgM Antibody against IgG Antibody Binding to Antigen, So-Called Anti-Antibody, Reacts Mainly with F (ab’)₂ Fragment Possessing Antibody Activity] Rinsho Byori. 2017 Jan;65(1):13-18.
8: Defrance T, Aubry JP, Vanbervliet B, Banchereau J. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity J Immunol. 1986 Dec 15;137(12):3861-7.
9: Kawano M, Iwato K, Asaoku H, Tanabe O, Tanaka H, Ishikawa H, Imamura N, Kuramoto A. Heterogenous response of B cell chronic lymphocytic leukaemia (B-CLL) cells to anti-human IgM antibody (anti-mu) and B cell stimulatory factor 1 (BSF-1) Br J Haematol. 1989 Jan;71(1):47-51.
10: Fukuda S, Chida E, Kuroda T, Kashiwamura M, Inuyama Y. An anti-mumps IgM antibody level in the serum of idiopathic sudden sensorineural hearing loss Auris Nasus Larynx. 2001 May;28 Suppl:S3-5.

Products Related to Anti Human IgM Antibody Conjugated to DyLight 488: Antibodies